Cargando…

Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial

Detalles Bibliográficos
Autores principales: Omi, Naomi, Shiba, Hideki, Nishimura, Eisaku, Tsukamoto, Sakuka, Maruki-Uchida, Hiroko, Oda, Masaya, Morita, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805538/
https://www.ncbi.nlm.nih.gov/pubmed/31639004
http://dx.doi.org/10.1186/s12970-019-0315-6
_version_ 1783461409083883520
author Omi, Naomi
Shiba, Hideki
Nishimura, Eisaku
Tsukamoto, Sakuka
Maruki-Uchida, Hiroko
Oda, Masaya
Morita, Minoru
author_facet Omi, Naomi
Shiba, Hideki
Nishimura, Eisaku
Tsukamoto, Sakuka
Maruki-Uchida, Hiroko
Oda, Masaya
Morita, Minoru
author_sort Omi, Naomi
collection PubMed
description
format Online
Article
Text
id pubmed-6805538
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68055382019-10-24 Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial Omi, Naomi Shiba, Hideki Nishimura, Eisaku Tsukamoto, Sakuka Maruki-Uchida, Hiroko Oda, Masaya Morita, Minoru J Int Soc Sports Nutr Correction BioMed Central 2019-10-21 /pmc/articles/PMC6805538/ /pubmed/31639004 http://dx.doi.org/10.1186/s12970-019-0315-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Omi, Naomi
Shiba, Hideki
Nishimura, Eisaku
Tsukamoto, Sakuka
Maruki-Uchida, Hiroko
Oda, Masaya
Morita, Minoru
Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
title Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
title_full Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
title_fullStr Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
title_full_unstemmed Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
title_short Correction to: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
title_sort correction to: effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, doubleblind trial
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805538/
https://www.ncbi.nlm.nih.gov/pubmed/31639004
http://dx.doi.org/10.1186/s12970-019-0315-6
work_keys_str_mv AT ominaomi correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial
AT shibahideki correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial
AT nishimuraeisaku correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial
AT tsukamotosakuka correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial
AT marukiuchidahiroko correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial
AT odamasaya correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial
AT moritaminoru correctiontoeffectsofenzymaticallymodifiedisoquercitrininsupplementaryproteinpowderonathletebodycompositionarandomizedplacebocontrolleddoubleblindtrial